CLINICAL TRIALS PROFILE FOR LO SIMPESSE
✉ Email this page to a colleague
All Clinical Trials for LO SIMPESSE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT06071442 ↗ | Potential Drug Interaction Study Between Vemircopan and Rosuvastatin, Metformin, Levonorgestrel/Ethinyl Estradiol-containing Oral Contraceptives, and Carbamazepine | Completed | Alexion Pharmaceuticals, Inc. | Phase 1 | 2024-01-17 | This study will investigate the potential drug interactions between vemircopan and metformin, rosuvastatin, levonorgestrel/ ethinyl estradiol (LNG/EE)-containing oral contraceptive(s) (OCs), and carbamazepine in healthy participants. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for LO SIMPESSE
Condition Name
Clinical Trial Locations for LO SIMPESSE
Trials by Country
Clinical Trial Progress for LO SIMPESSE
Clinical Trial Phase
Clinical Trial Sponsors for LO SIMPESSE
Sponsor Name
